US
US Medical Device Reprocessing Market Industry Trends and Forecast to 2034: Segmented by (Product, Service, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
US · 2024–2034 · estimates
Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
US (this report) at $1.81 Bn.
Canada at 13.9% a year.Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$3.30 Bn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $1.62 Bn | — | — |
| 2025 (base) | $1.81 Bn | +$197.1 Mn | — |
| 2026 (forecast) | $2.03 Bn | +$221.2 Mn | +12.2% |
| 2027 (forecast) | $2.28 Bn | +$248.2 Mn | +25.9% |
| 2028 (forecast) | $2.56 Bn | +$278.4 Mn | +41.2% |
| 2029 (forecast) | $2.87 Bn | +$312.4 Mn | +58.5% |
| 2030 (forecast) | $3.22 Bn | +$350.5 Mn | +77.8% |
| 2031 (forecast) | $3.62 Bn | +$393.3 Mn | +99.5% |
| 2032 (forecast) | $4.06 Bn | +$441.3 Mn | +123.8% |
| 2033 (forecast) | $4.55 Bn | +$495.1 Mn | +151.2% |
| 2034 (forecast) | $5.11 Bn | +$555.5 Mn | +181.8% |
Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
US (this report)
$1.81 Bn
Canada
$341.5 Mn
China
$327.4 Mn
Japan
$224.7 Mn
Germany
$129.2 Mn
UK
$104.5 Mn
France
$102.3 Mn
Ecuador
$85.5 Mn
Brazil
$84.5 Mn
Italy
$81.0 Mn
Spain
$76.9 Mn
India
$74.6 Mn
Saudi Arabia
$63.5 Mn
Mexico
$60.5 Mn
Australia
$47.8 Mn
Russia
$40.9 Mn
New Zealand
$36.9 Mn
South Africa
$27.2 Mn
UAE
$20.8 Mn
Egypt
$12.6 Mn
Philippines
$8.5 Mn
Hong Kong
$5.9 Mn
Malaysia
$5.7 Mn
Singapore
$4.7 Mn
Thailand
$4.0 Mn
Kenya
$2.4 Mn
Medical device reprocessing cleans, tests and sterilises single-use devices so they can be safely used again.
Key segments of the medical Device Reprocessing market include product (Cardiovascular Devices, Laparoscopic Devices and Orthopedic Devices) and service (Third-Party Reprocessing and In-House).
Staff shortages, rising patient numbers, pressure to cut costs and better connected technology are driving the medical Device Reprocessing market. Hospitals are investing in efficiency and patient safety.
Smart hospitals, automation and new hospitals in fast-growing countries give the medical Device Reprocessing market room to grow.
Tight hospital budgets, long buying cycles, integration with old systems and staff training needs hold back the medical Device Reprocessing market.
The medical Device Reprocessing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Licensing, quality standards and payment models from public and private payers shape how medical Device Reprocessing services are delivered and paid for in US. Government health programs and insurance coverage are key to access.
What doctors and scientists are doing in Medical Device Reprocessing right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.
[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.
[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
From our blog
Digital Health · US
Digital Health · US
Medical Devices · US
Medical Devices · US
Medical Devices · US
Medical Devices · US